AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

10812	Companies
234245	Keywords
163041	Articles
125258	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 11/25/2024 at 17:45, 1 year 8 months ago

Combating downy mildew in vines: Trials show the effectiveness of the biocontrol product AXPERA on downy mildew in vines under difficult conditions in 2024
Amoéba and IFV+ successfully tested AXPERA, a new amoeba lysate-based biofungicide, against downy mildew in vines in south-west France. AXPERA shows promising effectiveness in reducing fungal disease symptoms

AMOEBA Biofungicide AXPERA IFV+ Downy Mildew
BRIEF

published on 11/21/2024 at 17:50, 1 year 8 months ago

Amoéba publishes an article on its cosmetic innovation

AMOEBA Innovation Cosmetic Willaertia Lysate Skin Aging
PRESS RELEASE

published on 11/21/2024 at 17:45, 1 year 8 months ago

Amoéba announces the publication of a first scientific article on the efficacy of its innovation in cosmetics
Amoéba announces publication of a scientific article on the efficacy of Willaertia lysate in Cosmetics journal. Discover the natural microbiological solution's benefits for skin anti-aging

AMOEBA Willaertia Lysate Cosmetics Journal Skin Anti-aging Microbiological Solution
BRIEF

published on 10/07/2024 at 17:50, 1 year 10 months ago

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 year 10 months ago

Amoéba: Publication of the half-year financial report at 30 June 2024
Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions

AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
BRIEF

published on 10/03/2024 at 17:50, 1 year 10 months ago

Amoéba confirms its strategic pivot in the first half of 2024

AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 year 10 months ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF

published on 10/02/2024 at 17:50, 1 year 10 months ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets
BRIEF

published on 08/28/2024 at 17:50, 1 year 11 months ago

Amoéba Prepares for US Launch of AXPERA Product Line by 2025

Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 11 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA

Accesswire

Published on 08/08/2026 at 00:00, 1 day 2 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 day 3 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 3 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 4 hours ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 4 hours ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/09/2026 at 00:01, 2 hours 49 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 10 hours 25 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 3 hours ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 7 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 7 hours ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries

Les Echos

Published on 08/07/2026 at 18:54, 1 day 7 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 8 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 9 hours ago

Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 18 hours ago

Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/06/2026 at 18:26, 2 days 8 hours ago

Air Liquide voting rights as of July 31st 2026

View all LES ECHOS COMFI WIRE